Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065683
Filing Date
2025-05-07
Accepted
2025-05-07 16:15:25
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxst-20250331.htm   iXBRL 10-Q 2585594
2 EX-31.1 rxst-ex31_1.htm EX-31.1 31526
3 EX-31.2 rxst-ex31_2.htm EX-31.2 31490
4 EX-32.1 rxst-ex32_1.htm EX-32.1 14685
5 EX-32.2 rxst-ex32_2.htm EX-32.2 14726
  Complete submission text file 0000950170-25-065683.txt   9837750

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rxst-20250331.xsd EX-101.SCH 1572669
68 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20250331_htm.xml XML 1547615
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40690 | Film No.: 25921582
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)